These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 34547367)

  • 1. Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations.
    Ziegler D; Tesfaye S; Spallone V; Gurieva I; Al Kaabi J; Mankovsky B; Martinka E; Radulian G; Nguyen KT; Stirban AO; Tankova T; Varkonyi T; Freeman R; Kempler P; Boulton AJ
    Diabetes Res Clin Pract; 2022 Apr; 186():109063. PubMed ID: 34547367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diabetic polyneuropathy].
    Ziegler D
    Internist (Berl); 2020 Mar; 61(3):243-253. PubMed ID: 32086529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current concepts in the management of diabetic polyneuropathy.
    Ziegler D; Papanas N; Schnell O; Nguyen BDT; Nguyen KT; Kulkantrakorn K; Deerochanawong C
    J Diabetes Investig; 2021 Apr; 12(4):464-475. PubMed ID: 32918837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Tools, Biomarkers, and Treatments in Diabetic polyneuropathy and Cardiovascular Autonomic Neuropathy.
    Bönhof GJ; Herder C; Ziegler D
    Curr Diabetes Rev; 2022; 18(5):e120421192781. PubMed ID: 33845748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropathic pain is not adequately treated in the older general population: Results from the KORA F4 survey.
    Meisinger C; Bongaerts BWC; Heier M; Amann U; Kowall B; Herder C; Rückert-Eheberg IM; Rathmann W; Ziegler D
    Pharmacoepidemiol Drug Saf; 2018 Jul; 27(7):806-814. PubMed ID: 29797371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Pharmacological Treatment of Painful Diabetic Neuropathy: A Narrative Review.
    Ardeleanu V; Toma A; Pafili K; Papanas N; Motofei I; Diaconu CC; Rizzo M; Stoian AP
    Medicina (Kaunas); 2020 Jan; 56(1):. PubMed ID: 31936646
    [No Abstract]   [Full Text] [Related]  

  • 7. Painful and painless neuropathies are distinct and largely undiagnosed entities in subjects participating in an educational initiative (PROTECT study).
    Ziegler D; Landgraf R; Lobmann R; Reiners K; Rett K; Schnell O; Strom A
    Diabetes Res Clin Pract; 2018 May; 139():147-154. PubMed ID: 29518491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frontiers in diagnostic and therapeutic approaches in diabetic sensorimotor neuropathy (DSPN).
    Sharma S; Rayman G
    Front Endocrinol (Lausanne); 2023; 14():1165505. PubMed ID: 37274325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whither pathogenetic treatments for diabetic polyneuropathy?
    Boulton AJ; Kempler P; Ametov A; Ziegler D
    Diabetes Metab Res Rev; 2013 Jul; 29(5):327-33. PubMed ID: 23381942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenetic treatments for diabetic peripheral neuropathy.
    Ziegler D
    Diabetes Res Clin Pract; 2023 Dec; 206 Suppl 1():110764. PubMed ID: 38245327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current concepts in the management of diabetic polyneuropathy.
    Ziegler D
    Curr Diabetes Rev; 2011 May; 7(3):208-20. PubMed ID: 21534920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensory phenotype and risk factors for painful diabetic neuropathy: a cross-sectional observational study.
    Raputova J; Srotova I; Vlckova E; Sommer C; Üçeyler N; Birklein F; Rittner HL; Rebhorn C; Adamova B; Kovalova I; Kralickova Nekvapilova E; Forer L; Belobradkova J; Olsovsky J; Weber P; Dusek L; Jarkovsky J; Bednarik J
    Pain; 2017 Dec; 158(12):2340-2353. PubMed ID: 28858986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic Neuropathy.
    Zakin E; Abrams R; Simpson DM
    Semin Neurol; 2019 Oct; 39(5):560-569. PubMed ID: 31639839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of diabetic polyneuropathy: Update 2006.
    Ziegler D
    Ann N Y Acad Sci; 2006 Nov; 1084():250-66. PubMed ID: 17151306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging drugs for diabetic peripheral neuropathy and neuropathic pain.
    Papanas N; Ziegler D
    Expert Opin Emerg Drugs; 2016 Dec; 21(4):393-407. PubMed ID: 27813425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Composite nerve conduction scores and signs for diagnosis and somatic staging of diabetic polyneuropathy: Mid North American ethnic cohort survey.
    Davies JL; Lodermeier KA; Klein DM; Carter RE; Dyck PJB; Litchy WJ; Dyck PJ
    Muscle Nerve; 2023 Jul; 68(1):29-38. PubMed ID: 36734298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy.
    Sloan G; Selvarajah D; Tesfaye S
    Nat Rev Endocrinol; 2021 Jul; 17(7):400-420. PubMed ID: 34050323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathways in the diagnosis and management of diabetic polyneuropathy.
    Kaku M; Vinik A; Simpson DM
    Curr Diab Rep; 2015 Jun; 15(6):609. PubMed ID: 25899758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical appraisal of the use of alpha lipoic acid (thioctic acid) in the treatment of symptomatic diabetic polyneuropathy.
    McIlduff CE; Rutkove SB
    Ther Clin Risk Manag; 2011; 7():377-85. PubMed ID: 21941444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BOND study: a randomised double-blind, placebo-controlled trial over 12 months to assess the effects of benfotiamine on morphometric, neurophysiological and clinical measures in patients with type 2 diabetes with symptomatic polyneuropathy.
    Bönhof GJ; Sipola G; Strom A; Herder C; Strassburger K; Knebel B; Reule C; Wollmann JC; Icks A; Al-Hasani H; Roden M; Kuss O; Ziegler D
    BMJ Open; 2022 Feb; 12(2):e057142. PubMed ID: 35115359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.